This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We are once more indebted to the Barcelona Meningococcal Disease Surveillance Group¹ for a further study based on patients enrolled in their ongoing study of meningococcal infections. In their prior publication,² the authors asserted that preadmission antibiotics significantly decreased the risk of a fatal outcome. In response to a query,³ the authors expanded their presentation of data to reveal that (1) preadmission antibiotic therapy occurred more frequently in subacute and acute presentations and (2) a statistically significant effect on mortality of preadmission antibiotics occurred only in the acute and not in either the subacute or fulminant forms of disease.⁴ Apparently using the same cohort of patients, the authors now conclude that preadmission antibiotics not only improve mortality but also decrease the incidence of morbidity in survivors. The types of sequelae that were lessened in severity or prevented by this protective effect are not delineated. In both publications, the preadmission antibiotics . . . [Full Text of this Article]

RELATED ARTICLE

Meningococcal Disease in a Large Urban Population (Barcelona, 1987-1992): Predictors of Dismal Prognosis
Nicolau Barquet, Pere Domingo, Joan A. Caylà, Julià González, Carlos Rodrigo, Pedro Fernández-Viladrich, Fernando A. Moraga-Llop, Francesc Marco, Julio Vázquez, Juan A. Sáez-Nieto, Julio Casal, Jaume Canela, Màrius Foz, and for the Barcelona Meningococcal Disease Surveillance Group
Arch Intern Med. 1999;159(19):2329-2340.
ABSTRACT | FULL TEXT